Download
China approves domestic COVID-19 therapy for emergency use
CGTN

China's National Medical Products Administration on Wednesday approved a domestic COVID-19 therapy for emergency use.

The approved BRII-196/BRII-198 is a COVID-19 neutralizing monoclonal antibody combination therapy.

Search Trends